Caxton Associates LLP Invests $780,000 in Intuitive Surgical, Inc. $ISRG

Caxton Associates LLP acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the first quarter, according to its most recent filing with the SEC. The firm acquired 1,575 shares of the medical equipment provider’s stock, valued at approximately $780,000.

Other large investors have also recently made changes to their positions in the company. Castleark Management LLC lifted its stake in shares of Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock valued at $47,221,000 after purchasing an additional 2,990 shares during the period. Arlington Trust Co LLC lifted its stake in shares of Intuitive Surgical by 34.5% in the 1st quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider’s stock valued at $369,000 after purchasing an additional 191 shares during the period. Aveo Capital Partners LLC lifted its stake in shares of Intuitive Surgical by 37.4% in the 1st quarter. Aveo Capital Partners LLC now owns 727 shares of the medical equipment provider’s stock valued at $390,000 after purchasing an additional 198 shares during the period. Aaron Wealth Advisors LLC lifted its stake in shares of Intuitive Surgical by 3.2% in the 1st quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider’s stock valued at $1,243,000 after purchasing an additional 78 shares during the period. Finally, Longbow Finance SA increased its stake in shares of Intuitive Surgical by 132.0% in the 1st quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider’s stock worth $9,756,000 after acquiring an additional 11,209 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other news, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares in the company, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares of the company’s stock, valued at $504,898.14. This represents a 23.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 over the last quarter. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Trading Down 3.8%

Intuitive Surgical stock opened at $449.98 on Thursday. The business’s fifty day simple moving average is $489.31 and its two-hundred day simple moving average is $510.50. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The company has a market capitalization of $161.31 billion, a price-to-earnings ratio of 62.76, a price-to-earnings-growth ratio of 4.90 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. During the same quarter in the previous year, the business earned $1.78 earnings per share. The company’s revenue was up 21.4% on a year-over-year basis. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Ratings Changes

Several brokerages recently issued reports on ISRG. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, July 26th. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Royal Bank Of Canada reiterated an “outperform” rating and set a $615.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Finally, BTIG Research boosted their target price on Intuitive Surgical from $566.00 to $571.00 and gave the stock a “buy” rating in a report on Wednesday, July 23rd. Thirteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.